Abstract
Background
The therapeutic benefits of microsurgery for unruptured brain AVM remain unclear.
Methods
A series of 97 microsurgically resected unruptured brain AVM was analyzed in terms of postoperative morbidity and lifetime loss of quality-adjusted life-years (QALY). For comparison, the natural risk of becoming disabled was modeled on the basis of published data.
Results
Discharge morbidity was recorded in 11 of the 69 of Spetzler–Martin (SM) grade 1 and 2 AVMs (16 %), eight of 22 (36 %) grade 3, and four of six grade 4 (67 %), permanent morbidity >mRS 1 in 3 (4.3 %) grade 1 and 2, four (18 %) grade 3, and three (50 %) grade 4. Treatment inflicted loss of QALY amounted to 0.5 years for SM grade 1–2, 2.5 years grade 3, 7.3 years for grade 4. For the SM grades 1 and 2, the treatment-related loss of 0.5 QALY was met by the natural course after 2.7–4.3 years. For the Spetzler–Martin grades 3 and 4, the treatment-induced loss QALY was not met by the natural risk within a foreseeable time. Permanent morbidity and treatment inflicted loss of QALY of patients younger than 39 years was lower than that of older patients (7 vs. 15 % and 1.0 vs. 2.1 QALY).
Conclusions
Microsurgically managed SM grades 1 and 2 fared better than the modeled natural course but grades 3 and 4 AVM did not benefit from surgery. Younger patients appear to fare more favorably than older patients.
Similar content being viewed by others
References
Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, van Beijnum J, Josephson CB, Wilkinson T, Wedderburn CJ, Chandy Z, St George EJ, Sellar RJ, Warlow CP, Scottish Audit of Intracranial Vascular Malformations Collaborators (2014) Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 311(16):1661–1669
Bervini D, Morgan MK, Ritson EA, Heller G (2014) Surgery for unruptured arteriovenous malformations of the brain is better than conservative management for selected cases: a prospective cohort study. J Neurosurg 121(4):878–890
Bervini D, Morgan MK, Ritson EA, Heller G (2014) Surgery for unruptured arteriovenous malformations of the brain is better than conservative management for selected cases: a prospective cohort study. Neurochirurgie 60(6):327
Blicher JU, Nielsen JF (2008) Does long-term outcome after intensive inpatient rehabilitation of acquired brain injury depend on etiology? NeuroRehabilitation 23(2):175–183
Brown RD Jr, Wiebers DO, Forbes G, O’Fallon WM, Piepgras DG, Marsh WR, Maciunas RJ (1988) The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 68(3):352–357
Choi JH, Mast H, Sciacca RR, Hartmann A, Khaw AV, Mohr JP, Sacco RL, Stapf C (2006) Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke 37(5):1243–1247
Crawford PM, West CR, Chadwick DW, Shaw MD (1986) Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 49(1):1–10
da Costa L, Wallace MC, Ter Brugge KG, O’Kelly C, Willinsky RA, Tymianski M (2009) The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke 40(1):100–105
Elhammady MS, Heros RC (2014) Editorial. Management of incidental cerebral AVMs in the post-ARUBA era. J Neurosurg 121(5):1011–1014
Graf CJ, Perret GE, Torner JC (1983) Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 58(3):331–337
Gross BA, Du R (2013) Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg 118(2):437–443
Guo Y, Saunders T, Su H, Kim H, Akkoc D, Saloner DA, Hetts SW, Hess C, Lawton MT, Bollen AW, Pourmohamad T, McCulloch CE, Tihan T, Young WL, University of California, San Francisco Brain Arteriovenous Malformation (UCSF bAVM) Study Project (2012) Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture. Stroke 43(5):1240–1246
Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, Sidney S, Young WL (2004) Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke 35(7):1697–1702
Hartmann A, Mast H, Mohr JP, Koennecke HC, Osipov A, Pile-Spellman J, Duong DH, Young WL (1998) Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 29(5):931–934
Hernesniemi JA, Dashti R, Juvela S, Väärt K, Niemelä M, Laakso A (2008) Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 63(5):823–829
Kelly AG, Holloway RG (2010) Health state preferences and decision-making after malignant middle cerebral artery infarctions. Neurology 75(8):682–687
Kim H, McCulloch CE, Johnston SC, Lawton MT, Sidney S, Young WL (2010) Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol 171(12):1317–1322
Kim H, Al-Shahi Salman R, McCulloch CE, Stapf C, Young WL, MARS Coinvestigators (2014) Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology 83(7):590–597
Korja M, Bervini D, Assaad N, Morgan MK (2014) Role of surgery in the management of brain arteriovenous malformations: prospective cohort study. Stroke 45(12):3549–3555
Laakso A, Dashti R, Seppänen J, Juvela S, Väärt K, Niemelä M, Sankila R, Hernesniemi JA (2008) Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery 63(2):244–253
Laakso A, Dashti R, Juvela S, Isarakul P, Niemelä M, Hernesniemi J (2011) Risk of hemorrhage in patients with untreated Spetzler–Martin grade IV and V arteriovenous malformations: a long-term follow-up study in 63 patients. Neurosurgery 68(2):372–377
Lawton MT, Du R, Tran MN, Achrol AS, McCulloch CE, Johnston SC, Quinnine NJ, Young WL (2005) Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery 56(3):485–493, discussion 485–93
Meling TR, Proust F, Gruber A, Niemela M, Regli L, Roche PH, Vajkoczy P (2014) On apples, oranges, and ARUBA. Acta Neurochir (Wien) 156(9):1775–1779
Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ, international ARUBA investigators (2014) Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 383(9917):614–621
Ondra SL, Troupp H, George ED, Schwab K (1990) The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 73(3):387–391
Pierot L, Cognard C, Spelle L (2004) Cerebral arteriovenous malformations: evaluation of the hemorrhagic risk and its morbidity. J Neuroradiol 31(5):369–375
Post PN, Stiggelbout AM, Wakker PP (2001) The utility of health states after stroke: a systematic review of the literature. Stroke 32:1425–1429
Rutledge WC, Abla AA, Nelson J, Halbach VV, Kim H, Lawton MT (2014) Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus 37(3):E8
Sahlein DH, Mora P, Becske T, Huang P, Jafar JJ, Connolly ES, Nelson PK (2014) Features predictive of brain arteriovenous malformation hemorrhage: extrapolation to a physiologic model. Stroke 45(7):1964–1970
Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP (2006) Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 66(9):1350–1355
van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJ, Al-Shahi Salman R, SIVMS Steering Committee and the Oxford Vascular Study (2009) Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain 132(Pt 2):537–543
van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJ, van der Sprenkel JW, Vandertop WP, Algra A, Klijn CJ (2011) Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 306(18):2011–2019
Yamada S, Takagi Y, Nozaki K, Kikuta K, Hashimoto N (2007) Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg 107(5):965–972
Disclosure
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steiger, HJ., Fischer, I., Rohn, B. et al. Microsurgical resection of Spetzler–Martin grades 1 and 2 unruptured brain arteriovenous malformations results in lower long-term morbidity and loss of quality-adjusted life-years (QALY) than conservative management—results of a single group series. Acta Neurochir 157, 1279–1287 (2015). https://doi.org/10.1007/s00701-015-2474-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-015-2474-9